1 occupational exposure to hiv: universal precautions and pep haivn harvard medical school aids...
TRANSCRIPT
1
Occupational Exposure to HIV: Universal Precautions and PEP
HAIVNHarvard Medical School
AIDS Initiative in Vietnam
2
Learning Objectives
By the end of this session, participants should be able to:
Explain the risk of HIV transmission after a single percutaneous exposure
Demonstrate “scoop” technique of recapping needles
List the steps involved in post-exposure prophylaxis (PEP)
Describe PEP regimens in Vietnam
3
HIV Transmission Through Occupational Exposure
HIV transmission as a result of an occupational exposure is a rare event
The majority of transmissions occur by exposure to HIV-infected blood
The overall risk of HIV transmission depends on the route and severity of exposure
4
Risk of HIV Transmission
Blood exposures Risk of HIV Transmission
Percutaneous needlesticks0.3%
(95% CI=0.2-0.5%)
Mucous membranes0.09%
(95% CI 0.006% -0.5%)
Intact Skin0%
(95% CI =0.0%-0.77%)
5
Factors that Increase Risk of Transmission
Factors that increase the risk of HIV transmission from a needle stick injury include exposure: • through a visibly bloody device• through a device used in an artery or vein• via a deep injury• from a source individual with more advanced
HIV disease and a high HIV viral load
6
Body Fluids and Risk for HIV Exposure
Potential Risk Blood Cerebrospinal fluid
(CSF) Pleural fluid Peritoneal fluid Any body fluid visibly
contaminated with blood
Negligible Risk* Urine Saliva Sputum Sweat Feces Vomitus
* If not visibly contaminated with blood
7
Questions: What does the term
“Universal Precautions” mean?
What are some examples of Universal Precautions?
8
Universal Precautions (1)
#1 Treat ALL blood and body fluids as if they are potentially infectious
Follow Universal Precautions
#2 Prevent needle sticks
Safely manage sharps
9
Universal Precautions (2)
Following universal precautions means minimizing exposure to blood and body fluids through:• Use of protective barriers• Hand hygiene• Safe injection practices• Environmental control of blood and
bodily fluids• Sharps management
10
1. Use of Protective Barriers
Procedure Gloves Gown Goggles/Face Protection
Giving an injection No No No
Drawing blood Yes No No
Irrigating a wound Yes Yes Yes
Performing an operation Yes Yes Yes
Guidelines on when to use protective barriers
11
2. Hand Hygiene
Prevents transmission of resistant organisms and infections• Before patient care• After blood/fluid contact, glove removal
Methods:• Hand washing• Use hand sanitizer
60-95% ethyl or isopropyl alcohol
http://www.cdc.gov/handhygiene
12
3. Safe Injection Practices
Use a sterile syringe and needle for every infection; use the correct intended medication
Place needle in a puncture-proof container right after use
Discard sharps waste appropriately
13
4. Environmental Control of Blood and Body Fluids
Spills in patient-care areas
Clean visible blood/fluid with towel and discard
Disinfect area• 1:100 dilution (500
ppm) of hypochlorite
Spills in laboratory areas
Soak towel and blood/fluid spill in disinfectant before discarding
Use more potent disinfectant• 1:10 dilution (5000
ppm) of hypochlorite
14
5. Sharps Management
Injuries can occur whenever a sharp is exposed in the work environment, therefore it is important to:
Organize work areas• Have sharps containers nearby
Avoid hand-passage of sharps Not recap needles, or: recap using a
one-handed “scoop technique”
15
“One-hand” Technique of Recapping Needles
16
Post-Exposure Prophylaxis (PEP)
17
Post-Exposure Prophylaxis (PEP)
The use of therapeutic agents to prevent infection following exposure to a pathogen
Types of occupational exposure include:• Percutaneous injury (needle-stick or cut
through the skin)• Contact of mucous membrane or non-intact
skin with bodily fluids that are potentially infectious
18
PEP Rationale (1)
Information about primary HIV infection indicates that systemic infection does not occur immediately
There is a brief delay between exposure to virus and appearance of HIV in the blood
During this “window of opportunity” antiretroviral treatment may prevent systemic infection
19
PEP Rationale (2)
Animal models show that following exposure to HIV:• immune cells at site of HIV entry become
infected within first 24 hours• infected cells move to regional lymph
nodes over next 24-48 hours• within 5 days HIV is detectable in the blood
ARVs given soon after exposure may prevent infection by blocking HIV replication in the few cells that are initially infected
20
Efficacy of Antiretroviral Therapy
Case Control study: 31 cases, 679 controls
Cases acquired HIV following an occupational exposure• 94% after needle stick (all hollow needles)
29% of cases received PEP (AZT) vs. 36% of controls
Risk for HIV infection reduced by ~81% in HCWs receiving AZT
Cardo D. NEJM 1997; 337:1485-90
Human data-CDC Needle Stick Surveillance Group
21
Steps for Post-Exposure Management
1. Treat the exposure site 2. Report the exposure to the manager and
complete the report form3. Assess the risk of exposure 4. Determine the HIV status of the source of
exposure 5. Determine the HIV status of the exposed
person.6. Counsel the exposed person.7. Provide ARV prophylaxis (if indicated)
22
National Guidelines on PEP Regimens (1)
Medications Indications2 drug regimen (basic regimen)
AZT+ 3TC
OR
d4t + 3TC
All exposures with risk
3 drug regimen AZT+ 3TC
OR
d4t + 3TC
Plus: LPV/r
In case source of exposure is
known to have or suspected of ARV
resistance
23
National Guidelines on PEP Regimens (2)
Dosages:• AZT: 300mg BID PO• 3TC: 150mg BID PO• d4T: 30mg BID PO• LPV/r: 400mg/100mg BID PO
Nevirapine is not recommended due to fulminant liver failure in 4 American HCW taking it for PEP
24
Suggested Post-Exposure Follow-up and Testing
Test health care worker for HIV after 4-6 weeks, 3 months, and 6 months
Conduct laboratory tests to monitor ARV side effects:• CBC, ALT at baseline and after 4 weeks
25
Risk of Seroconversion afterPercutaneous Occupational Exposure
Virus Range MeanHBV 2 – 40 % 30%
HCV 0 – 7 % 3 %
HIV 0.2 – 0.5 % 0.3%
HBV is 100x more transmissible than HIV!
26
Case Study, Part 1
A nurse sustains a percutaneous (needle stick) injury to her index finger
The source patient is a woman who is at the OPC for her second visit and is known to be HIV-infected
Her clinical status and CD4 count have not yet been established
27
Case Study: Questions
1. What steps should be taken immediately?
2. You are responsible for counseling the nurse about PEP. What is the risk of acquiring HIV from a known HIV-infected source patient? What questions about the incident could you ask her to assess her risk?
28
Case Study, Part 2 (1)
On questioning, the nurse reports that she was wearing gloves when her finger was stuck by a 21-gauge phlebotomy needle that had just been used to draw blood from the vein of the source patient
The needle was visibly bloody at the time she was stuck, and she is not sure if it was a ‘deep’ stick or not, but she says “it made my finger bleed” a lot.
29
Case Study, Part 2 (2)
She does not think she is pregnant She has never been tested for HIV
but has no reason to believe that she might have HIV infection
30
Case Study: Questions
3. What are your PEP recommendations for the nurse?
4. What additional testing and follow-up care should be performed for the exposed nurse? What additional advice and counseling would you offer?
31
Key Points
The term “Universal Precautions” means treating all blood and body fluids as if they are infectious
Risk of transmission from a single occupational exposure for:• HIV = 0.3%• HBV = 30%
PEP in Vietnam should follow MOH guidelines
32
Thank you!
Questions?